Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment

Table 8

Presence and geometric mean titres of antibodies against human papillomaviruses in CML patients prior to the start of the therapy and after achieving hematological and/or complete cytogenetic remission.

antibody presence
Sample	No.	HPV6	HPV11	HPV16	HPV18	HPV31	HPV33
First	11	6	5	3	3	3	1
Last	11	5	3	3	3	2	1
GMT
First	11	1.27	1.01	0.68	1.00	0.79	0.50
Last	11	1.08	0.88	0.65	0.75	0.61	0.38